Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Regul Toxicol Pharmacol ; 125: 105016, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34302895

RESUMEN

Although the 3Rs are broadly applied in nonclinical testing, a better appreciation of the 3Rs is needed in the field of differentiated or value-added pharmaceutical generics because the minor changes in formulation, dosage form, indication, and application route often do not require additional safety testing. The US FDA and the EU EMA have comprehensive regulations for such drugs based on quality, therapeutic equivalence, and safety guidelines. However, no scientific publications on how the concept of replacement and reduction from 3Rs principles can be applied in the safety assessment of differentiated generics were found in the public domain. In this review, we discuss the application of 3Rs in nonclinical testing requirements for differentiated generics. Practical examples are provided in the form of case studies from regulated markets. We highlight the need for utilization of existing data to establish equivalence (differentiated generic vs innovator) in efficacy and safety. The case studies indicate that data requirements from animal experiments have been reduced to a large extent in some major markets without compromising quality and safety. In this context, we also highlight the problem that on a global scale, a true reduction of animal experiments will only be achieved when all countries adopt similar practices.


Asunto(s)
Alternativas a las Pruebas en Animales/métodos , Medicamentos Genéricos/farmacocinética , Alternativas a las Pruebas en Animales/normas , Formas de Dosificación , Vías de Administración de Medicamentos , Quimioterapia Combinada , Medicamentos Genéricos/administración & dosificación , Medicamentos Genéricos/efectos adversos , Europa (Continente) , Humanos , Equivalencia Terapéutica , Estados Unidos , United States Food and Drug Administration
2.
Arch Toxicol ; 86(6): 831-8, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22441626

RESUMEN

This review aims to explore the toxicological aspects of mercury-based herbo-metallic preparations like cinnabar and "Rasasindura" that are primarily composed of mercuric sulfide (HgS). Cinnabar-containing preparations have been used extensively in Indian and Chinese systems of medicine for treatment of chronic ailments like syphilis, high fever, pneumonia, insomnia, nervous disorders, deafness, and paralysis of the tongue. Contrary to Western medicine, which does not promote the use of mercury due to its toxic effects, Indian and Chinese traditional practitioners believe that mercury-based formulations have potent therapeutic efficacy, while there is no toxicity due to the unique and repeated purification processes employed during preparation. However, lack of proper pharmacovigilance and widespread self-medication has resulted in undesirable effects to certain sections of the consumers of these preparations, which have contributed to the negative publicity for these forms of medicine. Variations in the quality of the preparations coupled with the lack of understanding of the differences in the recommended dosages and treatment strategies adopted by traditional medicine practitioners, further fuels concerns in the Western world on the safety and efficacy of traditional medicine. But in spite of these concerns, concerted efforts to understand the biological interactions and transformations of these preparations are yet to gain momentum. Although scattered reports on the toxicity of these preparations are available in literature, their mechanism of action has not been conclusively established. Long-term pharmacotherapeutic and in-depth toxicity studies are needed to address the apprehensions raised by these herbo-metallic preparations. This review highlights the lacunae in the studies conducted thus far, and assesses the need for further studies to provide significant data to establish the safety and efficacy of such preparations, as well as develop gold standards for stringent quality control of these preparations.


Asunto(s)
Medicina Tradicional/efectos adversos , Compuestos de Mercurio/toxicidad , Intoxicación por Mercurio/etiología , Extractos Vegetales/toxicidad , Antídotos/uso terapéutico , Humanos , Intoxicación por Mercurio/terapia , Farmacovigilancia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...